Detalhe da pesquisa
1.
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada.
Clin Colorectal Cancer
; 23(1): 46-57.e4, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007297
2.
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada.
Cancer Treat Rev
; 115: 102526, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924644
3.
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 6(12): e2346094, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051531
4.
Top 10 research priorities for early-stage colorectal cancer: a Canadian patient-oriented priority-setting partnership.
CMAJ Open
; 10(1): E278-E287, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35351780
5.
Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system.
Cancer Med
; 9(18): 6507-6514, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700475
6.
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study.
JAMA Oncol
; 6(6): 831-838, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32379280
7.
A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine.
J Pathol Clin Res
; 3(3): 179-190, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770102